Bicycle Therapeutics (BCYC) Operating Expenses (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Operating Expenses data on file, last reported at $55.2 million in Q2 2026.

• Quarterly Operating Expenses fell 38.35% year-over-year to $55.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $271.5 million (down 11.73% YoY) and the FY2025 annual result came in at $319.7 million, up 30.39% from the prior year.
• Operating Expenses retreated to $55.2 million in Q2 2026, from $66.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $89.5 million in Q2 2025 to a low of $31.2 million in Q1 2022.
• A 5-year average of $57.5 million and a median of $56.1 million in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 76.08% — and 2026, when it tumbled 38.35%.
• Tracing BCYC's Operating Expenses over 5 years: stood at $35.4 million in 2022, then surged by 68.28% to $59.6 million in 2023, then advanced by 19.82% to $71.4 million in 2024, then gained by 1.81% to $72.7 million in 2025, then dropped by 24.05% to $55.2 million in 2026.
• The last three Operating Expenses figures came in at $55.2 million (Q2 2026), $66.4 million (Q1 2026), and $72.7 million (Q4 2025), per Business Quant data.